124
Official USP Reference Standards Catalog
March–April 2009
Cross Reference List
Former
Cat. No.
00200-6
Cat.
No.
1184027
1008002
1008002
1021703
1021703
02200-3
1013024
02250-2
1057507
1023403
Former Description/Cross Reference
5-Acetamido-3-amino- 2, 4,6-triiodobenzoic Acid ( 50 mg)
(Limit Test)
alpha-d-2-Acetoxy-4-dimethylamino- 1,2-diphenyl-3-methyl-
butane
N-(Aminocarbonyl)-N-[([5-nitro-2-furanyl]-methylene)-amino]-
glycine ( 25 mg)
3-Amino-4-carboxamidopyrazole Hemisulfate ( 50 mg) (Limit
Test)
4-Amino-6-chloro- 1,3-benzenedisulfonamide ( 100 mg) (
Limit Test)
3-Amino-6-chloro-1-methyl-4-phenylcarbostyril ( 25 mg)
1023403
02380-0
02420-2
02240-6
2-Amino- 2’-chloro-5-nitrobenzophenone ( 25 mg) (Limit
Test)
4-Amino-6-chloro-N-3-methyl-m-benzenedisulfonamide
( 100 mg) (Limit Test)
2-Amino-4-chlorophenol ( 50 mg) (Limit Test)
1140338
1424018
1130527
02460-0
02490-5
3-Amino-4-(2-chloro-phenyl)-6-nitrocarbostyril ( 25 mg) (
Limit Test)
2-Amino- 2’,5-dichlorobenzophenone ( 25 mg) (Limit Test)
1140327
1370338
02610-6
3-Amino-4-phenoxy-5-sulfamoylbenzoic Acid ( 25 mg) (Limit
Test)
alpha-Aminopropiophenone Hydrochloride ( 50 mg) (Limit
Test)
Aprobarbital CIII (200 mg) (AS) DISCONTINUED
Azlocillin Sodium (200 mg) DISCONTINUED
Benzthiazide (200 mg) DISCONTINUED
5-Benzyl- 3,6-dioxo-2-piperazineacetic Acid (250 mg) (Limit
Test)
2-(4-Biphenylyl)propionic Acid ( 100 mg) (Limit Test)
1078325
02620-8
1096804
1042000
1046103
1060002
06300-0
N/A
N/A
N/A
1043728
07350-3
1285760
07480-1
07500-4
1076002
08650-5
1089004
1090003
1097501
1098355
11230-0
N,N’-Bis-( 1,3-dihydroxy-2-propyl)-5-amino- 2, 4,6-triiodoi-
sophthalamide ( 50 mg) (Limit Test)
4, 4’-Bis[4-(p-chlorophenyl)-4-hydroxypiperidino]-butyrophe-
none ( 25 mg) (Limit Test)
4, 4’-Bis[ 1, 2, 3,6-tetrahydro-4-(2-oxo-1-benzimidazolinyl)-1- N/A
pyridyl]butyrophenone ( 25 mg) DISCONTINUED
Calcium Formyltetrahydrofolate ( 50 mg) (AS) (For Qualitia-tive Use Only)
Cannabidiol CI ( 25 mg) (AS) DISCONTINUED
Cannabinol CI ( 25 mg) (AS) DISCONTINUED
Cefamandole Sodium (250 mg) DISCONTINUED
Cellulose Acetate Phthalate ( 125 mg)
p-Chlorobenzhydrylpiperazine ( 25 mg)
1344724
1303013
New Description
Diatrizoic Acid Related Compound A ( 50 mg) (5-Acetamido-3-
amino- 2, 4,6-triiodobenzoic Acid)
Propoxyphene Related Compound B ( 50 mg) (alpha-d-2-
Acetoxy-4-dimethylamino- 1,2-diphenyl-3-methylbutane)
Nitrofurantoin Related Compound A ( 25 mg) (N-(Aminocar-
bonyl)-N-[([5-nitro-2-furanyl]-methylene)-amino]-glycine)
Allopurinol Related Compound A ( 50 mg) (3-Amino-4-carbox-
amidopyrazole Hemisulfate)
Benzothiadiazine Related Compound A ( 100 mg) (4-Amino-6-
chloro- 1,3-benzenedisulfonamide)
Diazepam Related Compound B ( 25 mg) (3-Amino-6-chloro-
1-methyl-4-phenylcarbostyril)
Clonazepam Related Compound B ( 25 mg) (2-Amino- 2’-
chloro-5-nitrobenzophenone)
Methyclothiazide Related Compound A ( 100 mg) (4-Amino-6-
chloro-N-3-methyl-m-benzenedisulfonamide)
Chlorzoxazone Related Compound A ( 25 mg) ( 2-Amino-4-
chlorophenol)
Clonazepam Related Compound A ( 25 mg) (3-Amino-4-(2-
chlorophenyl)-6-nitrocarbostyril)
Lorazepam Related Compound B ( 25 mg) (2-Amino- 2’,5-
dichlorobenzophenone)
Bumetanide Related Compound A ( 25 mg) (3-Amino-4-
phenoxy-5-sulfamoylbenzoic Acid)
Cathinone Hydrochloride CI ( 50 mg) (
alpha-Aminopropiophenone Hydrochloride)
DISCONTINUED, Last Lot/Valid Use Date: F- 1 (02/07)
DISCONTINUED, Last Lot/Valid Use Date: F (06/08)
DISCONTINUED, Last Lot/Valid Use Date: F (06/08)
Aspartame Related Compound A ( 75 mg) (5-Benzyl- 3,6-
dioxo-2-piperazineacetic Acid)
Flurbiprofen Related Compound A ( 100 mg) (2-(4-Bipheny-
lyl)propionic Acid)
Iopamidol Related Compound A ( 50 mg) (N,N’-Bis-( 1,3-
dihydroxy-2-propyl)-5-amino- 2, 4,6-triiodoisophthalamide)
Haloperidol Related Compound A ( 25 mg) ( 4,4-Bis[4-p-
chlorophenyl)-4-hydroxypiperidino]-butyrophenone
DISCONTINUED, Last Lot/Valid Use Date: G (05/03)
1286027
N/A
N/A
N/A
1098355
1333058
11310-9
1370349
11320-0
1370350
11330-2
6-Chloro-4-(o-chloro-phenyl)-2-quinazolinecarboxaldehyde
( 25 mg) (Limit Test)
6-Chloro-4-(o-chloro-phenyl)-2-quinazolinecarboxylic Acid
( 25 mg) (Limit Test)
6-Chloro-4-(o-chloro-phenyl)-2-quinazoline Methanol
( 25 mg) (Limit Test)
1370360
Folic Acid Related Compound A ( 50 mg) (Calcium Formyltetrahydrofolate)
DISCONTINUED, Last Lot/Valid Use Date: F- 2 (05/08)
DISCONTINUED, Last Lot/Valid Use Date: F- 2 (05/02)
DISCONTINUED, Last Lot/Valid Use Date: F (12/07)
Cellacefate ( 125 mg) (Cellulose Acetate Phthalate)
Hydroxyzine Related Compound A ( 25 mg) (
p-Chlorobenzhydrylpiperazine)
Lorazepam Related Compound C ( 25 mg) (6-Chloro-4-(o-
chlorophenyl)-2-quinazolinecarboxaldehyde)
Lorazepam Related Compound D ( 25 mg) (6-Chloro-4-(o-
chlorophenyl)-2-quinazolinecarboxylic Acid)
Lorazepam Related Compound E ( 25 mg) (6-Chloro-4-(o-
chlorophenyl)-2-quinazoline Methanol)
www.usp.org
